Spectrum has launched the folate analog Fusilev (levoleucovorin injection). Fusilev is used to reduce toxicity of high-dose methotrexate (MTX) therapy in osteosarcoma and to decrease the toxicity and counteract the effects of impaired MTX elimination or inadvertent overdose of folic acid antagonists.

For more information call (949) 788-6700 or visit www.fusilev.com.

Click here to see the full Fusilev new product monograph.